Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 84,786 shares, an increase of 19,526.4% from the December 15th total of 432 shares. Based on an average trading volume of 118,101 shares, the days-to-cover ratio is presently 0.7 days. Based on an average trading volume of 118,101 shares, the days-to-cover ratio is presently 0.7 days.
Novozymes A/S Price Performance
Shares of NVZMY traded down $1.04 during mid-day trading on Monday, hitting $64.78. 43,117 shares of the stock were exchanged, compared to its average volume of 44,243. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61. The company has a market cap of $30.82 billion, a PE ratio of 38.33, a price-to-earnings-growth ratio of 1.22 and a beta of 1.09. Novozymes A/S has a 52-week low of $53.95 and a 52-week high of $75.99. The firm has a 50-day moving average of $62.77 and a two-hundred day moving average of $64.24.
About Novozymes A/S
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
See Also
- Five stocks we like better than Novozymes A/S
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
